389 related articles for article (PubMed ID: 21372253)
21. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
Joergensen C; Reinhard H; Schmedes A; Hansen PR; Wiinberg N; Petersen CL; Winther K; Parving HH; Jacobsen PK; Rossing P
Diabetes Care; 2012 Jan; 35(1):168-72. PubMed ID: 22040839
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
25. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease.
Inami T; Seino Y; Otsuka T; Yamamoto M; Kimata N; Murakami D; Takano M; Ohba T; Ibuki C; Mizuno K
J Cardiol; 2012 Sep; 60(3):180-6. PubMed ID: 22525967
[TBL] [Abstract][Full Text] [Related]
26. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S;
Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
[TBL] [Abstract][Full Text] [Related]
27. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
28. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
29. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
[TBL] [Abstract][Full Text] [Related]
30. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
31. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
32. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
[TBL] [Abstract][Full Text] [Related]
33. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery.
Schutt RC; Cevik C; Phy MP
Am J Cardiol; 2009 Jul; 104(1):137-40. PubMed ID: 19576335
[TBL] [Abstract][Full Text] [Related]
34. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
Kim JY; Lee EY; Jee JH; Lee BW; Chung JH; Jeun ES; Min YK; Lee MS; Kim KW; Lee MK
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S238-42. PubMed ID: 17490778
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
Lajer M; Tarnow L; Jorsal A; Parving HH
Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
[TBL] [Abstract][Full Text] [Related]
36. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
[TBL] [Abstract][Full Text] [Related]
37. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
38. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
[TBL] [Abstract][Full Text] [Related]
39. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
40. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
